Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Revenue $ 1,122 $ 59,505
Operating expenses    
Research and development (97,501) (98,269)
General and administrative (43,391) (43,601)
Total operating expenses (140,892) (141,870)
Operating loss (139,770) (82,365)
Interest income 2,772 2,849
Other income (expense), net 75 (15,501)
Loss before income taxes (136,923) (95,017)
Income tax expense (242) (497)
Net loss attributable to ordinary shareholders $ (137,165) $ (95,514)
Net loss per ordinary share - Basic and diluted    
Basic and diluted (in dollars per share) $ (0.22) $ (0.16)
Weighted average shares outstanding:    
Basic and diluted (in shares) 629,805,218 584,338,942
Development revenue    
Revenue $ 1,122 $ 20,391
License revenue    
Revenue   $ 39,114